David E. Anderson
2019
In 2019, David E. Anderson earned a total compensation of $881.7K as Chief Scientific Officer at VBI Vaccines, a 4% decrease compared to previous year.
Compensation breakdown
| Bonus | $88,200 |
|---|---|
| Option Awards | $429,000 |
| Salary | $360,000 |
| Other | $4,500 |
| Total | $881,700 |
Anderson received $429K in option awards, accounting for 49% of the total pay in 2019.
Anderson also received $88.2K in bonus, $360K in salary and $4.5K in other compensation.
Rankings
In 2019, David E. Anderson's compensation ranked 9,836th out of 13,971 executives tracked by ExecPay. In other words, Anderson earned more than 29.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,836 out of 13,971 | 30th |
Division Manufacturing | 3,970 out of 5,695 | 30th |
Major group Chemicals And Allied Products | 1,512 out of 2,194 | 31st |
Industry group Drugs | 1,292 out of 1,880 | 31st |
Industry Pharmaceutical Preparations | 959 out of 1,392 | 31st |
Source: SEC filing on April 28, 2020.
Anderson's colleagues
We found two more compensation records of executives who worked with David E. Anderson at VBI Vaccines in 2019.
News
VBI Vaccines CEO Jeffrey Baxter's 2023 pay falls 51% to $894K
April 29, 2024
VBI Vaccines CEO Jeffrey Baxter's 2022 pay falls 47% to $1.8M
May 1, 2023
VBI Vaccines CEO Jeffrey Baxter's 2021 pay jumps 54% to $3.5M
April 29, 2022
VBI Vaccines CEO Jeffrey Baxter's 2020 pay jumps 63% to $2.2M
April 26, 2021
VBI Vaccines CEO Jeffrey Baxter's 2019 pay slips 8% to $1.4M
April 28, 2020
VBI Vaccines CEO Jeffrey Baxter's 2018 pay jumps 81% to $1.5M
April 29, 2019